BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 6386643)

  • 1. Response of extrapancreatic immunoreactive glucagon to intraluminal nutrients in pancreatectomized dogs.
    Ohneda A; Kobayashi T; Nihei J
    Horm Metab Res; 1984 Jul; 16(7):344-8. PubMed ID: 6386643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of response of gut GLI to fat ingestion in dogs.
    Ohneda A; Kobayashi T; Nihei J
    Horm Metab Res; 1984 Dec; 16 Suppl 1():105-9. PubMed ID: 6398248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response of extrapancreatic glucagon to arginine in dogs.
    Ohneda A; Kobayashi T; Nihei J; Umezu M; Sakai T; Sanoyama K
    Tohoku J Exp Med; 1979 Sep; 129(1):45-54. PubMed ID: 494257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucagon deficiency and hyperaminoacidemia after total pancreatectomy.
    Boden G; Master RW; Rezvani I; Palmer JP; Lobe TE; Owen OE
    J Clin Invest; 1980 Mar; 65(3):706-16. PubMed ID: 6986412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of glucagon deficiency in the Houssay phenomenon of dogs.
    Nakabayashi H; Dobbs RE; Unger RH
    J Clin Invest; 1978 May; 61(5):1355-62. PubMed ID: 659597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extrapancreatic glucagon in control of glucose turnover in depancreatized dogs.
    Ross G; Lickley L; Vranic M
    Am J Physiol; 1978 Feb; 234(2):E213-19. PubMed ID: 623297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A-Cell and gut glucagon in normal and depancreatized dogs. Inhibition by somatostatin and insulin.
    Matsuyama T; Wider MD; Tanaka R; Shima K; Tarui S; Nishikawa M; Foà PP
    Diabete Metab; 1979 Jun; 5(2):141-7. PubMed ID: 478084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of insulin on the response of gut glucagon-like immunoreactivity (GLI) to oral glucose and food ingestion in the goose.
    Karmann H; Mialhe P
    Horm Metab Res; 1987 Feb; 19(2):47-52. PubMed ID: 3549502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of gastric glucagon immunoreactivity in pancreatectomized dogs.
    Ikei S; Mori K; Sakamoto Y; Ishii J; Watanabe O; Inoue M; Akagi M
    Jpn J Surg; 1980 Sep; 10(3):255-60. PubMed ID: 7012409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoreactive glucagon responses to oral glucose, insulin infusion and deprivation, and somatostatin in pancreatectomized man.
    Werner PL; Palmer JP
    Diabetes; 1978 Oct; 27(10):1005-12. PubMed ID: 700256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response of gut glucagon-like immunoreactivity to hypoglycemia in dogs.
    Ohneda A; Sasaki I; Naito H; Toda M; Ohneda M; Koizumi F
    Am J Physiol; 1989 Mar; 256(3 Pt 1):E431-8. PubMed ID: 2646947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absence of true pancreatic glucagon but persistence of circulating pancreatic glucagon-like immunoreactivity after pancreatectomy in pigs.
    Holst JJ; Kreutzfeldt M; Holm G; Jensen E; Poulsen JS; Sparsö B; Sparsö B; Schmidt A
    Diabete Metab; 1978 Jun; 4(2):75-9. PubMed ID: 680313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response of gastric inhibitory polypeptide (GIP) to oral administration of nutrients in normal and pancreatectomized dogs.
    Ohneda A; Kobayashi T; Nihei J
    Regul Pept; 1983 Feb; 5(3):263-72. PubMed ID: 6342065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucagon immunoreactivities and amino acid profile in plasma of duodenopancreatectomized patients.
    Muller WA; Berger M; Suter P; Cüppers HJ; Reiter J; Wyss T; Berchtold P; Schmidt FH; Assal JP; Renold AE
    J Clin Invest; 1979 May; 63(5):820-7. PubMed ID: 447830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistent pancreatic glucagon but not insulin response to arginine in pancreatectomized dogs.
    Mashiter K; Harding PE; Chou M; Mashiter GD; Stout J; Diamond D; Field JB
    Endocrinology; 1975 Mar; 96(3):678-93. PubMed ID: 1116479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of growth hormone on acute glucagon and insulin release.
    Sirek A; Vranic M; Sirek OV; Vigas M; Policova Z
    Am J Physiol; 1979 Aug; 237(2):E107-12. PubMed ID: 380363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement and partial characterization of immunoreactive glucagon in gastrointestinal tissues of dogs.
    Morita S; Doi K; Yip CC; Vranic M
    Diabetes; 1976 Nov; 25(11):1018-25. PubMed ID: 186345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The physicochemical nature and biological function of extrapancreatic immunoreactive glucagon.
    Ikei S; Mori K; Sakamoto Y; Ishii J; Watanabe O; Inoue M; Akagi M
    Gastroenterol Jpn; 1980; 15(3):241-6. PubMed ID: 7399222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peculiar glucagon processing in the intestine is the genesis of the paradoxical rise of serum pancreatic glucagon in patients after total pancreatectomy.
    Tanjoh K; Tomita R; Fukuzawa M; Hayashi N
    Hepatogastroenterology; 2003; 50(50):535-40. PubMed ID: 12749267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of total pancreatectomy on the secretion of gut glucagon in humans.
    Yasui K
    Jpn J Surg; 1983 Mar; 13(2):122-9. PubMed ID: 6350663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.